Search Results - "Arkhammar, Per"
-
1
Safety update on the use of recombinant activated factor VII in approved indications
Published in Blood reviews (01-06-2015)“…Abstract This updated safety review summarises the large body of safety data available on the use of recombinant activated factor VII (rFVIIa) in approved…”
Get full text
Journal Article -
2
Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders
Published in Current medicinal chemistry (01-06-2004)“…The pattern of insulin release is crucial for regulation of glucose and lipid haemostasis. Deficient insulin release causes hyperglycemia and diabetes, whereas…”
Get more information
Journal Article -
3
-
4
New 3-Alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-Dioxide Derivatives Activate ATP-Sensitive Potassium Channels of Pancreatic Beta Cells
Published in Journal of medicinal chemistry (13-07-2006)“…Compound 1a (NN414) is a potent opener of Kir6.2/SUR1 K ATP channels. Compound 1a inhibits insulin release in vitro and in vivo and preserves beta cell…”
Get full text
Journal Article -
5
Separation of the Glucose-Stimulated Cytoplasmic and Mitochondrial NAD(P)H Responses in Pancreatic Islet β Cells
Published in Proceedings of the National Academy of Sciences - PNAS (09-05-2000)“…Two-photon excitation microscopy was used to image and quantify NAD(P)H autofluorescence from intact pancreatic islets under glucose stimulation. At maximal…”
Get full text
Journal Article -
6
6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-Dioxide Derivatives Potently and Selectively Activate ATP Sensitive Potassium Channels of Pancreatic β-Cells
Published in Journal of medicinal chemistry (12-09-2002)“…6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives were synthesized and characterized as activators of adenosine 5‘-triphosphate…”
Get full text
Journal Article -
7
Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 analyzer
Published in Journal of biomolecular screening (01-02-2005)“…The PI3-kinase/Akt pathway is an important cell survival pathway that is deregulated in the majority of human cancers. Despite the apparent druggability of…”
Get more information
Journal Article -
8
Synthesis and pharmacological evaluation of 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyanomethylsulfonylphenyl)acylamide derivatives as potential activators of ATP sensitive potassium channels
Published in Bioorganic & medicinal chemistry (03-01-2005)“…1,2,4-Thiadiazine derivatives, like 3-methyl-7-chlorobenzo-4H-1,2,4-thiadiazine 1,1-dioxide, diazoxide and 7-chloro-3-isopropylamino-4H-benzo-1,2,4-thiadiazine…”
Get full text
Journal Article -
9
Possible role of an ischemic preconditioning-like response mechanism in K(ATP) channel opener-mediated protection against streptozotocin-induced suppression of rat pancreatic islet function
Published in Biochemical pharmacology (15-12-2008)“…Potassium channel openers (KCOs) decrease insulin secretion from beta-cells. Some KCOs also protect against damage to beta-cell function and type 1 diabetes in…”
Get full text
Journal Article -
10
Arylcyanoguanidines as Activators of Kir6.2/SUR1KATP Channels and Inhibitors of Insulin Release
Published in Journal of medicinal chemistry (03-06-2004)“…Phenylcyanoguanidines substituted with lipophilic electron-withdrawing functional groups, e.g. N-cyano-N‘-[3,5-bis-(trifluoromethyl)phenyl]-N‘…”
Get full text
Journal Article -
11
Dihydroxyacetone-induced Oscillations in Cytoplasmic Free Ca2+ and the ATP/ADP Ratio in Pancreatic β-Cells at Substimulatory Glucose
Published in The Journal of biological chemistry (17-10-2003)“…Glucose stimulation of pancreatic β-cells causes oscillatory influx of Ca2+, leading to pulsatile insulin secretion. We have proposed that this is due to…”
Get full text
Journal Article -
12
Glucose- and Interleukin-1β-Induced β-Cell Apoptosis Requires Ca2+ Influx and Extracellular Signal-Regulated Kinase (ERK) 1/2 Activation and Is Prevented by a Sulfonylurea Receptor 1/Inwardly Rectifying K+ Channel 6.2 (SUR/Kir6.2) Selective Potassium Channel Opener in Human Islets
Published in Diabetes (New York, N.Y.) (01-07-2004)“…Glucose- and Interleukin-1β-Induced β-Cell Apoptosis Requires Ca 2+ Influx and Extracellular Signal-Regulated Kinase (ERK) 1/2 Activation and Is Prevented by a…”
Get full text
Journal Article -
13
2-(4-methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 KATP channels
Published in Bioorganic & medicinal chemistry letters (01-12-2004)Get full text
Journal Article -
14
Su1794 TOLERABILITY, SAFETY, AND CLINICAL PHARMACOLOGY OF AZD7798, A DEPLETING ANTIBODY TARGETING CCR9
Published in Gastroenterology (New York, N.Y. 1943) (18-05-2024)Get full text
Journal Article -
15
Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cells
Published in Bioorganic & medicinal chemistry letters (09-07-2001)“…3,5-Disubstituted-phenylcyanoguanidines have been identified as activators of SUR1/Kir6.2 potassium channels and as potent inhibitors of insulin release from…”
Get full text
Journal Article -
16
Arylcyanoguanidines as activators of Kir6.2/SUR1K ATP channels and inhibitors of insulin release
Published in Journal of medicinal chemistry (03-06-2004)“…Phenylcyanoguanidines substituted with lipophilic electron-withdrawing functional groups, e.g. N-cyano-N'-[3,5-bis-(trifluoromethyl)phenyl]-N'…”
Get full text
Journal Article -
17
Activation by adrenaline of a low-conductance G protein-dependent K + channel in mouse pancreatic B cells
Published in Nature (London) (03-01-1991)“…Insulin is produced and secreted by the B cells in the endocrine pancreas. In vivo, insulin secretion is under the control of a number of metabolic, neural and…”
Get full text
Journal Article -
18
Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors
Published in Blood reviews (01-06-2015)“…Abstract The availability of recombinant activated factor VII (rFVIIa, eptacog alfa activated) has greatly advanced the care of patients with haemophilia A or…”
Get full text
Journal Article -
19
Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease , a Multinational Observational Database Cohort
Published in International journal of chronic obstructive pulmonary disease (2024)“…Purpose: This study evaluated the long-term safety of roflumilast in patients with chronic obstructive pulmonary disease or chronic bronchitis using electronic…”
Get full text
Journal Article -
20
Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study
Published in International journal of chronic obstructive pulmonary disease (31-08-2024)“…This study evaluated the long-term safety of roflumilast in patients with chronic obstructive pulmonary disease or chronic bronchitis using electronic…”
Get full text
Journal Article